Sreenu Guntha founded AAP Pharma Technologies, India Pvt Ltd in January 2009, establishing a company focused on providing innovative pharmaceutical solutions.
Under Sreenu Guntha's leadership, AAP Pharma Technologies has expanded its services and product offerings, contributing to advancements in pharmaceutical technology in India.
Prior to founding AAP Pharma, Sreenu Guntha served as Senior Director at Sai Advantium Pharma Ltd from July 2007 until December 2008, driving key projects and initiatives within the organization.
From February 2001 to July 2007, Sreenu Guntha held various roles at Albany Molecular Research Inc, starting as Senior Research Scientist II and advancing to Group Leader, indicating a strong background in research and development in the pharmaceutical sector.
During the tenure at Albany Molecular Research Inc, Sreenu Guntha contributed to the development of significant pharmaceutical products, showcasing expertise in drug formulation and testing.
Sreenu Guntha’s experience spans over two decades in the pharmaceutical industry, highlighting a robust understanding of the complexities and challenges faced in drug development and manufacturing.
As a founder, Sreenu Guntha has faced challenges common in establishing new enterprises, including resource allocation, market competition, and regulatory compliance, which have been navigated successfully.
AAP Pharma Technologies has become recognized in the industry for its commitment to quality and innovation, significantly impacting the competitive landscape of the Indian pharmaceutical market.
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Aap Pharma Technologies, India Pvt Ltd corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Sreenu Guntha's net worth? Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them? Through Aap Pharma Technologies, India Pvt Ltd's official communication channels.
Is this an official profile? No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible
information and independent research. While accuracy is prioritized, content may not always reflect the
latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured
has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication
channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)